ISLAND PHARMACEUTICALS LIMITED — Director's Dealing 2021

Apr 12, 2021

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	ISLAND PHARMACEUTICALS LIMITED
ABN	48 641 183 842

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	DR DAVID FOSTER
Date of appointment	1 October 2020

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

5,146,829 fully paid ordinary shares - escrowed for 24 months from listing

177,778 unlisted options exercisable at $0.3125 each on or before 30 April 2024 – escrowed for 24 months from date of listing

177,778 unlisted options exercisable at $0.3750 each on or before 30 April 2024 – escrowed for 24 months from date of listing

177,777 unlisted options exercisable at $0.4375 each on or before 30 April 2024 – escrowed for 24 months from date of listing

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

	ppendix 3Xitial Director’s Interest Notice	ppendix 3Xitial Director’s Interest Notice
	rt 2 – Director’s relevant interests in securit		ies of whi	ch the director is n	ot the
	gistered holderthe case of a trust, this includes interests in the trust made		available by	the responsible entity of t	he trust
Name of holder & nature ofinterestNote: Provide details of the circumstances givingrise to the relevant interest.Mr Terry Foster <Foster LivingTrust>– beneficiary under the trust	Name of holder & nature oftt	Numbe	r & class	of Securities
	eresote: Provide details of the circumstances givingse to the relevant interest
	.
	Mr Terry Foster <Foster Living	64,564	fully pa	id ordinary share	s (13,094 of
	rust>– beneficiary under the trust	whichof listin	are escrog).	ed for 24 months	from the date

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
No. and class of securities to whichinterest relates	N/A

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002